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A B S T R A C T
Background: The Crimean-Congo hemorrhagic fever (CCHF) virus is transmitted by tick bites and by
contact with the blood or tissues of infected patients and livestock. This study was designed to
investigate the genome of CCHF virus in saliva and urine samples of patients with CCHF.
Methods: Eight patients with laboratory-conﬁrmed CCHF were included in the study. The diagnosis was
made by detection of viral RNA in blood by real-time reverse transcriptase-polymerase chain reaction
(real-time RT-PCR). Samples of saliva from six patients and samples of urine from three patients were
collected at the same time as the blood samples and analyzed for viral RNA.
Results: The genome of CCHF viruswas detected in the saliva fromﬁve of the six patients and in the urine
from two of the three patients. The levels of viral load in the saliva and urine samples were similar to
those in the blood samples in all but one patient, inwhomhigher levels were detected in blood compared
to saliva or urine.
Conclusions: This study shows that during human infection with CCHF virus, viral genomes are present
in the saliva and urine. Further studies to isolate infectious viruses from these ﬂuids and to study
whether they represent an infectious risk are underway.
 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Crimean-Congo hemorrhagic fever (CCHF) is a potentially
fatal and acute infection caused by the CCHF virus, which
belongs to the Nairovirus genus of the family Bunyaviridae.1
CCHF is transmitted by tick bites or by close contact with blood
or tissues of infected humans or livestock with viremia.1 CCHF is
a public health problem in more than 30 countries in Africa,
Asia, Southeast Europe, and the Middle East.2 Since 2002, CCHF
has also occurred in the central, northern, and eastern regions of
Turkey.3–5 Fever, headache, myalgia, malaise, diarrhea, nausea,
and vomiting are common clinical signs of the disease. The
outcome can be fatal in severe cases, with bleeding and organ
failure.3–6
To our knowledge, there is no study reported in the literature
that has investigated the viral genome of CCHF in samples of saliva* Corresponding author. Tel.: +90 312 5084840; fax: +90 312 3126876.
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1201-9712/$36.00 – see front matter  2009 International Society for Infectious Disea
doi:10.1016/j.ijid.2009.04.018and urine. This study was designed to ﬁll the void in the literature
and to initiate further studies on this subject.
2. Materials and methods
2.1. Patients
This prospective study was conducted at Ankara Numune
Education and Research Hospital during the spring and summer
seasons of 2008. The viral genome of CCHFwas measured in blood,
saliva, and urine from the patients admitted to the hospital with a
possible diagnosis of CCHF. Speciﬁcally, samples were collected
aseptically upon admission and were immediately transported to
the national reference laboratories for detection of viral genome of
CCHF and viral loads. A TaqMan-based 1-step reverse transcrip-
tase-polymerase chain reaction (real-time RT-PCR) was used for
the detection and quantiﬁcation of CCHF viral RNA in the blood,
saliva, and urine.7
Patients with conﬁrmed CCHF, in whom CCHF viral RNA
was detected in blood samples, were included in the study.
Patients with hematuria, hemoglobinuria, epistaxis, gingivalses. Published by Elsevier Ltd. All rights reserved.
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Table 1
Results of CCHF real-time RT-PCR tests and viral loads
Patient
number
Duration of
symptomsa
(days)
Blood viral load
(copies/ml)
Saliva viral load
(copies/ml)
Urine viral load
(copies/ml)
1 2 7  104 2  105 NT
2 6 3  103 6  104 NT
3 10 5  105 1  104 NT
4 6 8  103 6  105 NT
5 4 2  107 Negative 7  103
6 7 4  104 NT 1  104
7 7 8  104 NT Negative
8 6 1  104 8  105 NT
CCHF, Crimean–Congo hemorrhagic fever; RT-PCR, reverse transcriptase polymer-
ase chain reaction; NT, not tested.
a Time between the beginning of symptoms and collection of specimens.
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2.2. Real-time RT-PCR assay
A TaqMan-based 1-step reverse transcriptase PCR (real-time
RT-PCR) was used for detection and quantiﬁcation of CCHF viral
RNA. Real-time RT-PCRwas performed as described by Yapar et al.7
Brieﬂy, 5ml of viral RNA was added to 20ml of the mixture
containing 5 pmol of each primer, 4 pmol of TaqMan probe,
0.2 mM of each dNTP (containing dUTP), and 6 mM magnesium
chloride. The cycle conditionswere carried out as follows: 42 8C for
40 min, 95 8C for 10 min; and then 40 PCR cycles as follows: 15 s at
95 8C, 1 min at 60 8C. The assay was run on a Perkin–Elmer 7700
Sequence Detection System by using the combination of reverse
transcriptase (MBI Fermentas) and Hot Start Taq DNA polymerase
(Bioron GmBH, Germany). Detailed data analyses for copies/ml
were as per Yapar et al.7
3. Results
A diagnosis of CCHF was conﬁrmed in eight patients who had a
positive blood real-time RT-PCR test for CCHF virus. Saliva samples
of six patients and urine samples of three patients were available
for testing for the presence of viral genomes of CCHF. Three
patients were female. All of the patients had a history of tick bite,
fever, myalgia, malaise, nausea, and vomiting. Two patients had a
maculopapular rash. There were no bleedingmanifestations in any
of the patients. Thrombocytopenia (59–110  109 cells/l ) and
leukopenia (1–3  109 cells/l ) were detected in all patients except
one. The activated partial thromboplastin time (aPTT) was slightly
elevated in only one patient. All patients had high serum levels of
aspartate aminotransferase (AST), lactate dehydrogenase (LDH),
and creatine phosphokinase (CPK). The mean duration from the
beginning of symptoms until the collection of specimens was
6  2.3 days. CCHF RNA was detected in the saliva from ﬁve of six
patients (83.3%) and in the urine from two of three patients (66.7%)
(Table 1). All samples were cell free during microscopic examination.
Viral loads in blood, saliva, and urine are shown in Table 1.
Symptomatic treatment was given to the patients and all survived.
4. Discussion
To our knowledge, this study is the ﬁrst showing that CCHF viral
RNA can be detected in saliva and urine from CCHF-infected
patients. The study also demonstrates that the viral loads in saliva
and urine samples are similar to those in blood. These ﬁndings are
consistent with other viral hemorrhagic fevers, such as Lassa fever,
dengue fever, and hantavirus renal syndrome. In fact, there aredocumented cases of other viral hemorrhagic fever viruses being
detected in saliva or in urine by PCR methods, and it has been
reported that these samples could be used for diagnostic
purposes.8–10 Additionally, it has been suggested that speciﬁc
IgM antibodies in saliva are useful markers for the detection of
dengue infection.11
In this brief work, we have only studied the detection of viral
genomes of CCHF in saliva and urine and made comparisons to the
viral RNA load in blood samples. We have not carried out virus
isolation from these samples and thus it has not been possible for
us to determine that viruses are present in these body ﬂuids.
Similarly we have not studied whether saliva and urine are
infectious or not, and it remains unclear if these body ﬂuids play a
role in human-to-human transmission.
According to reports from the Turkish Ministry of Health, about
60% of patients with CCHF have a history of tick bite.12 However,
the source of infection in the other 40% of patients is often
unknown. In addition, seroepidemiological studies have shown
that in endemic areas, some individuals had CCHF IgG antibodies in
their serum samples even though they did not have symptomatic
disease.13,14 Therefore, the role of other body ﬂuids like saliva and
urine in the transmission of the CCHF virus should be investigated
in further studies.
In conclusion, the study has provided scientiﬁc evidence that
viral genomes of CCHF virus are present in saliva and urine during a
clinical infection with the disease. At the moment it is not possible
to determine if these body ﬂuids present infectious hazards;
however this is the subject of further research, and work to isolate
infectious viruses fromurine and saliva is underway. In addition, as
with other viral hemorrhagic fevers, detection of the genome of
CCHF in urine or saliva may serve as a noninvasive alternative
diagnostic method, particularly when blood collection is difﬁcult.
Further studies with larger patient populations are needed to
conﬁrm these ﬁndings and interpretations.
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